Biden Nominates New Science Advisor

If the Senate confirms her appointment, Arati Prabhakar will become the first woman, person of color, and immigrant to head the Office of Science and Technology Policy.

Written byAndy Carstens
| 2 min read
portrait photo of Arati Prabhakar
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Update (September 23): The Senate voted 56 to 40 yesterday to confirm Arati Prabhakar as director of the Office of Science and Technology Policy. She is expected to assume the role in the next week or two, Bloomberg Law reports.

Yesterday (June 21), President Joe Biden nominated Arati Prabhakar to become his chief science advisor, a role she would assume as director of the Office of Science and Technology Policy. Becoming head of the OSTP requires Senate confirmation, a process that could take several months, according to Nature. Prabhakar would become the first Senate-confirmed woman, person of color, and immigrant to head the OSTP and oversee shaping and executing the President’s science agenda, reports the Associated Press.

“Dr. Prabhakar is a brilliant and highly-respected engineer and applied physicist and will lead the Office of Science and Technology Policy to leverage science, technology, and innovation to expand our possibilities, solve our ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens is a freelance science journalist who is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has previously appeared in AudubonSlateThem, and Aidsmap. View his full portfolio at www.andycarstens.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies